Insufficient scRNA-seq data for expression of PHETA2 at single-cell level.
Insufficient scRNA-seq data for expression of PHETA2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1099.32 | 328 / 328 | 99% | 36.69 | 176 / 178 |
breast | 100% | 1104.75 | 459 / 459 | 99% | 32.19 | 1103 / 1118 |
intestine | 100% | 1189.98 | 965 / 966 | 98% | 25.73 | 518 / 527 |
stomach | 100% | 1142.81 | 359 / 359 | 98% | 22.65 | 280 / 286 |
lung | 100% | 1111.23 | 577 / 578 | 98% | 27.34 | 1128 / 1155 |
uterus | 100% | 1415.72 | 170 / 170 | 97% | 34.06 | 446 / 459 |
prostate | 100% | 1141.71 | 244 / 245 | 97% | 29.28 | 486 / 502 |
skin | 100% | 1157.02 | 1807 / 1809 | 96% | 43.14 | 455 / 472 |
esophagus | 100% | 1198.34 | 1444 / 1445 | 96% | 18.72 | 176 / 183 |
ovary | 96% | 556.32 | 173 / 180 | 97% | 17.29 | 415 / 430 |
bladder | 100% | 1205.86 | 21 / 21 | 91% | 23.09 | 459 / 504 |
thymus | 100% | 686.13 | 650 / 653 | 90% | 11.39 | 543 / 605 |
kidney | 98% | 553.89 | 87 / 89 | 84% | 11.90 | 758 / 901 |
adrenal gland | 97% | 456.57 | 250 / 258 | 67% | 13.17 | 155 / 230 |
adipose | 100% | 1138.17 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 40.73 | 80 / 80 |
spleen | 100% | 852.44 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 40.22 | 1 / 1 |
blood vessel | 100% | 1291.50 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 563.98 | 846 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 29.32 | 43 / 45 |
lymph node | 0% | 0 | 0 / 0 | 90% | 9.17 | 26 / 29 |
brain | 12% | 25.53 | 321 / 2642 | 37% | 5.14 | 259 / 705 |
liver | 14% | 39.40 | 32 / 226 | 30% | 5.40 | 123 / 406 |
peripheral blood | 36% | 97.92 | 334 / 929 | 0% | 0 | 0 / 0 |
muscle | 32% | 76.84 | 259 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042147 | Biological process | retrograde transport, endosome to Golgi |
GO_0001881 | Biological process | receptor recycling |
GO_0007032 | Biological process | endosome organization |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0005829 | Cellular component | cytosol |
GO_0030136 | Cellular component | clathrin-coated vesicle |
GO_0055037 | Cellular component | recycling endosome |
GO_0005769 | Cellular component | early endosome |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PHETA2 |
Protein name | Sesquipedalian-2 (Ses2) (27 kDa inositol polyphosphate phosphatase interacting protein B) (IPIP27B) (PH domain-containing endocytic trafficking adaptor 2) PH domain containing endocytic trafficking adaptor 2 |
Synonyms | FAM109B |
Description | FUNCTION: Plays a role in endocytic trafficking. Required for receptor recycling from endosomes, both to the trans-Golgi network and the plasma membrane. . |
Accessions | ENST00000321753.8 Q6ICB4 B1AHR3 ENST00000419475.1 |